Head-to-head for women
MadeMed vs REMEVi
MadeMed and REMEVi both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
MadeMed
Ranked #6 for women · Grade B
Luna Fit
Best for: Women who expect to titrate and want to know today what month six costs, and who want an oral route available without switching provider.
Visit MadeMedREMEVi
Higher scoreRanked #31 for women · Grade B
Luna Fit
Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.
Visit REMEViThe verdict for women
REMEVi edges out MadeMed on the Luna Fit Score, 85 to 84 (B vs B). Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing. The reasoning behind that number is in the REMEVi scorecard.
MadeMed is still a genuine option — a LegitScript-verified compounded program that charges one flat price at every dose — so titrating up to a working dose never quietly raises the bill. Weigh the six women's-health factors below against your own priorities; what we found reviewing MadeMed goes through each of them, and if neither of these two is the one, what women pick instead of MadeMed widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | MadeMed | REMEVi |
|---|---|---|
| Luna Fit Score | 84/100 · B | 85/100 · B |
| Overall rank | #6 | #31 |
| Semaglutide | $239/mo quarterly (from $199/mo on 6 months) | $199/mo |
| Tirzepatide | $399/mo quarterly (from $369/mo on 6 months) | $269/mo |
| Coverage | 40 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Luna Fit
MadeMed
Ranked #6 · Grade B
What we like
- One price at every dose, published dose by dose — semaglutide $239/mo from 0.25mg to 2.4mg, tirzepatide $399/mo from 2.5mg to 15mg
- LegitScript verified, with board-certified physician review and US compounding pharmacies
- Oral semaglutide and oral tirzepatide are both offered alongside the injections
The caveats
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- 40 states rather than nationwide — check yours before you start
- Tirzepatide is among the pricier entries in this ranking at $399/mo quarterly
Luna Fit
REMEVi
Ranked #31 · Grade B
What we like
- LegitScript-accredited and available in all 50 states
- Both molecules disclosed, tirzepatide for insulin-resistant PCOS
- Clear, predictable pricing
The caveats
- Higher-end pricing — $199 semaglutide, $269 tirzepatide
- No oral or brand-name option; general program without hormone specialization
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither MadeMed nor REMEVi is only worth comparing with the other. MadeMed is also written up against CoreAge Rx, 9 points apart on the Luna Fit Score — see MadeMed vs CoreAge Rx for women. REMEVi is also written up against CoreAge Rx, 8 points apart — see the REMEVi–CoreAge Rx head-to-head.
- MadeMed vs CoreAge Rx
- MadeMed vs Enhance MD
- MadeMed vs yourEra
- REMEVi vs Sesame Care
- REMEVi vs HealthRX
- REMEVi vs Trimi
Or browse the full comparison hub.